Epilepsy

New, non-invasive methods can help detect which epilepsy patients may be having seizures and allow clinicians to respond rapidly or to better plan surgeries for patients who are refractory to medical therapy.

Find the latest developments in epilepsy research on the pages that follow and test your knowledge by answering some of the difficult questions.

Graph theory applied to epilepsy, an abbreviated QOLCE, promising new interventions for neonatal seizures, a minipump to deliver drugs-the latest developments in epilepsy diagnosis and patient care.

This new guideline could change the approach many physicians take to treating a first seizure--and could improve patients’ lives.

Quick, how many of the following-eslicarbazepine, ezogabine, parampanel-do you recognize? These new entries into the medical armamentarium were highlighted at the AAN 2015 Annual Meeting.

A non-psychoactive component of the marijuana plant, cannabidiol in liquid form decreased seizures by an average of 50% across multiple types of severe epilepsy.

Advances in neurology science and patient care continue to make news even before the doors to the AAN 2015 Annual Meeting officially open on Saturday. These are the top stories.

A major advance in epilepsy treatment may be found in the first direct brain responsive neurostimulator, upcoming AAN meeting will have an epilepsy focus, and other top stories.

ADHD lowers the quality of life in adults with epilepsy; epilepsy is associated with social deprivation and increased risk of venous thromboembolism: details of these recent findings in this slide show.

The ultimate cause is found in only about half of patients, so improved understanding of the prognostic and diagnostic features is of high priority.

Favorable long-term results for patients with hard-to-treat epilepsy who undergo brain surgery offer good information for decision-making and counseling.

Symptoms occur in nearly 1 in 5 adults who have epilepsy. Their presence may have severe implications for patients’ quality of life.

The largest study of its kind shows that 8 in 1000 people have epilepsy--a distinctly higher incidence than previously thought. Details and implications in this podcast.

By localizing the portion of the brain responsible for seizures and envisioning long-term outcomes, this imaging combination helps guide clinical decision making.

This yellow CSF was drawn from an HIV-positive man who presented with status epilepticus. What is the most likely cause?

What happens before the demyelinating lesions of MS appear? Does smoking confer protection against Parkinson disease? How is NMDA receptor-associated disease reversed? Here are 4 fine papers from 2014 that set out to answer these questions.

New research sheds light on epilepsy concerns, particularly the link between cardiac abnormalities and sudden unexpected death.

Get to the root of the latest research findings on nervous system disorders and test your brainpower with this quick 5-question quiz.

The ketogenic and the modified Atkins diets, high in fat and low in carbohydrates, could reduce these seizures, suggesting that clinicians bring them into the treatment discussion.

Patients with juvenile myoclonic epilepsy appear to have modest cognitive defects and imaging abnormalities early on that are unlikely to be associated with anti-epileptic therapy. This is a clear departure from traditional teaching.

The possibility of SUDEP should serve as a powerful motivator for improved adherence and active attempts at seizure control with new medications, neurostimulation, and epilepsy surgery.

Choosing a technique for a particular drug resistant patient is a judgment call based on the results of the patient’s monitoring, clinician experience, and many other factors.

The knowledge that a patient is at high or low risk for late seizures has the potential to improve patient care.

Persons with epilepsy have a higher prevalence of comorbid conditions-psychiatric disorders in particular-than the general population.

As clinicians, we can daily apply knowledge learned from a few patients with pure amnesia to patients we see often-those who have memory deficits, such as so-called Mild Cognitive Impairment and neurodegenerative diseases, such as Alzheimer's.